Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.
We interviewed Paul, our new Director QA/QC & EHS to learn about his career and his passion for quality.
On the third of May last year the Ministry of Health, Welfare, and Sport (VWS) announced the sale of Intravacc B.V. and on December 28, 2023 VWS…
Intravacc publishes 2022 annual report
Looking back on a successful Bio International 2023 in Boston!
Meet the new Business Development Team
Dutch State Announces the Sale of Intravacc B.V. (The Netherlands)
Intravacc publishes 2021 Annual Report and announces expansion of its management team and board of directors
Intravacc announces positive pre-clinical data for its OMV-based Lyme vaccine
Intravacc Announces Appointment of Nathalie Laarakker as Chief Financial Officer
Intravacc appoints three Supervisory Board members
